Evogene Ltd.
EVGN
$0.76
-$0.02-2.05%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1,343.33% | 17.66% | 106.47% | -91.52% | 39.12% |
| Total Depreciation and Amortization | -40.36% | 383.33% | -33.48% | -68.38% | 2.48% |
| Total Amortization of Deferred Charges | 0.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 142.08% | 323.79% | -830.33% | 306.60% | 180.79% |
| Change in Net Operating Assets | 41.01% | 548.68% | -166.95% | 70.67% | -204.19% |
| Cash from Operations | 41.11% | 57.82% | 23.02% | -29.16% | 38.82% |
| Capital Expenditure | 98.14% | 92.00% | -274.42% | 36.57% | 4.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.58% | -130.51% | 1,916.00% | -44.20% | 1,801.48% |
| Cash from Investing | 17.18% | -130.81% | 1,594.54% | -44.65% | 16,663.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 57.10% | 42.68% | -46.23% | 49.76% | -- |
| Issuance of Common Stock | -- | 5,060.24% | -100.00% | -31.37% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -218.27% | -40.00% | 420.00% | 13.79% | -100.58% |
| Cash from Financing | -24.27% | 2,847.68% | -40.14% | -31.00% | -23.30% |
| Foreign Exchange rate Adjustments | 228.57% | 228.57% | -107.07% | 139.29% | 71.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.99% | 134.31% | 160.74% | -74.18% | 137.15% |